Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
PaperCitations, authors & open-access status
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 692 citations, 2021 year and green oa status.
692
Citations
2021
Year
green
OA Status